focus -WSS

focus

author：Wikipedia 2025-08-06 05:21:36 - browse：9

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Virtual Event: March of the Biosimilars

WSS

Neuroscience’s long legacy of racism

Insmed lung disease drug hits target in key Phase 3 trial

Average age of first period drops to 11.9 years, study shows

AI used to predict Covid

Stigma and the return of syphilis

Addiction doctors spar with methadone clinics over legislation

entertainment

focus

explore

Psychedelics group wrestles with new pharma identity

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Latest bird flu infection made farmworker sicker than earlier cases

State Dept. review finds Biden bears some blame for Afghanistan failures

Average age of first period drops to 11.9 years, study shows

Guidelines to prevent youth baseball injuries need more muscle

Focused ultrasound for uterine fibroids: an uphill battle

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

SCOTUS questions limit to govt efforts to fight misinformation

explore

Leading voice in opioid treatment defends methadone clinic system

CVS Caremark has created a new ploy: the drug ‘rebate credit’

App could help diagnose ear infections more accurately — and at home

Gene editing the human germline: What are the risks?

Prosthetic arm enables patients to feel the objects they grip

Insmed lung disease drug hits target in key Phase 3 trial

hotspot

entertainment

focus

Wikipedia